Refreshing results…
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1
UploadOrganometallic Conjugates of the Drug Sulfadoxine for Combatting Antimicrobial Resistance
Download from api.wiley.comMissing publications? Search for publications with a matching author name.